What You Should Know:
- Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
- The company’s latest advancement integrates a series of artificial intelligence (AI) models into a unified agent that quickly and securely reviews patient records and assesses eligibility, transforming a
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Understanding Antibody Structure: A Comprehensive Guide for Beginners
Antibodies are key components of the immune system. They act as the body's defense system against invading pathogens such as bacteria and viruses. Basically, antibodies are proteins that are formed by the immune system to protect the body from antigens, which are harmful foreign substances. Therefore, antibodies aim at the antigens wishing to destroy them by signaling immune cells. The unique characteristic of antibodies is that they have the ability to identify and remember specific organisms
Read More
PathAI Partners to Deploy First AI-Powered Biospecimen Solutions
What You Should Know:
- PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery Life Sciences, a leading biospecimens and specialty lab testing company, to offer Discovery’s customers enhanced, AI-enabled digital and quantitative insights from biospecimens to better inform drug and diagnostic development.
- This collaboration marks a milestone as the first at-scale deployment of AI technologies into a leading commercial
Read More
ATOMIC-Meso Trial: A New Take Against Pleural Mesothelioma
Pleural mesothelioma is a type of an aggressive cancer that develops in the tissue that surrounds the lung cavity. It is known to be primarily caused by asbestos exposure. Asbestos was largely used as a material in products revolving construction, automobile, and insulation. It is apparently still used in the said products today in buildings and houses in the U.S. The clear disparity between its latency period, which generally takes decades, compared to its fatal ramifications and little chance
Read More
Lindus Health Raises $55M to Accelerate AI-Driven Clinical Trials
What You Should Know:
- Lindus Health, a company transforming the clinical trial landscape with its tech-first approach raises $55M in Series B funding round led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp.
- The funding will fuel the continued development of Lindus Health's AI technology and eClinical platform, Citrus™, and support the company's mission to make clinical trials faster, more reliable,
Read More
Beyond Chatbots: How AI is Reshaping Medical Information Delivery
The demand for accurate and timely medical information has never been greater. As healthcare providers and patients navigate an increasingly complex landscape of therapies and treatments, the need for accessible and reliable MI is critical to delivering quality care. Organizations are moving away from traditional call centers and embracing artificial intelligence-enhanced digital solutions to meet these growing demands. This shift addresses the rising volume and complexity of inquiries and
Read More
SandboxAQ and Google Cloud Partner to Optimize Large Quantitative Models
What You Should Know:
- SandboxAQ, a leader in artificial intelligence (AI) solutions, today announced a strategic partnership with Google Cloud to integrate and optimize its platform of Large Quantitative Models (LQMs) on Google Cloud.
- The collaboration will leverage Google Cloud's robust infrastructure and advanced capabilities to enhance the performance and scalability of SandboxAQ's AI solutions while making them more accessible to customers through Google Cloud
Read More
Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data
What You Should Know:
- Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.
- The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper
Read More
TetraScience & Microsoft Partner to Advance Scientific AI in Biopharma
What You Should Know:
- TetraScience, a provider of scientific data cloud solutions announced a strategic collaboration with Microsoft to accelerate the adoption of artificial intelligence (AI) in the biopharmaceutical industry.
- The strategic partnership combines TetraScience's Scientific Data and AI Cloud with the power and security of Microsoft Azure, creating a robust platform for scientific organizations to extract valuable insights from their complex experimental
Read More
Is AI Failing Drug Development? The Unseen Challenges
For over a decade, we've heard about AI's transformative potential in therapeutics (Tx), but where's the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there something the AI experts aren't telling us?
First, some facts. The process of Tx development—from early clinical trials to FDA approval—is excruciatingly slow (over 10 years), expensive (over $2B, especially for immunotherapy drugs), and comes with a low probability of success (5% in Immune-Oncology, and similarly
Read More
